Application
Fig1: Western blot analysis of DDX5 on human DDX5 recombinant protein using anti-DDX5 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of DDX5 on HEK293 (1) and DDX5-hIgGFc transfected HEK293 (2) cell lysate using anti-DDX5 antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of DDX5 on different cell lysate using anti-DDX5 antibody at 1/1,000 dilution. Positive control: Lane1: HT-29 Lane2: Hela Lane3: NIH/3T3 Lane4: COS7 Lane5: SW620 Lane6: Jurkat Lane7: A431 Lane8: MCF-7
Application
Fig4:Immunohistochemical analysis of paraffin-embedded human bladder cancer tissue using anti-DDX5 antibody. Counter stained with hematoxylin.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissue using anti-DDX5 antibody. Counter stained with hematoxylin.
Application
Fig6: Flow cytometric analysis of Hela cells with DDX5 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).